RBC Maintains Outperform Rating on Xylem, $125 Price Target
RBC Capital maintained its Outperform rating on Xylem and a $125 price target.
Story updates
04:19:18 PM UTC
SquawkNews
Xylem Is Maintained at Outperform by RBC Capital